Skip to content

A study to determine the role of stellate ganglion block in prevention of cerebral vasospasm in aneurysmal subarachnoid haemorrhage patients.

A prospective randomized study to determine the effect of perioperative stellate ganglion block on cerebral vasospasm in aneurysmal subarachnoid haemorrhage patients. - Nil

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/065407
Enrollment
20
Registered
2024-04-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: SGB groub: After routine disinfection and preparation of the block site, under ultrasound guidance 10 mL of 0.375% ropivacaine will be injected into the surface of the longus colli musc

Sponsors

All India Institute of Medical Sciences New Delhi
Lead Sponsor
All India Institute of Medical Sciences New Delhi
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 18 years to 65 years, Anterior circulation aneurysms, Planned aneurysm clipping, Pre operative Hunt and Hess grade I II and III

Exclusion criteria

Exclusion criteria: ASA physical status more than III Posterior circulation aneurysm Multiple aneurysms Allergy to known local anaesthetics Pregnant women

Design outcomes

Primary

MeasureTime frame
PRIMARY OUTCOME - To compare the incidence of TCD defined cerebral vasospasm MCA or ACA velocity more than 120cm per second in patients receiving perioperative Stellate Ganglion Block versus standard treatment group which is the control group here.Timepoint: TCD will be used to measure cerebral blood flow velocity in MCA or ACA preoperatively day 0 and after surgery on day 1,2,3,5 and 7th day.

Secondary

MeasureTime frame
Incidence of symptomatic cerebral vasospasm within 14 days after aSAH Any additional intervention done for cerebral vasospasm Peri operative complications Total length of stay in the ICU and hospital Functional outcome at 3 months Timepoint: Till discharge from hospital

Countries

India

Contacts

Public ContactDr Suman Sokhal

All India Institute of medical Sciences, New Delhi

sumansokhal82@gmail.com8700330755

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026